Loading clinical trials...
Loading clinical trials...
A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV, & COVID-19 and LIAISON PLEX Respiratory (RSP) Flex Assays in Symptomatic Patients in Australia
Conditions
Interventions
LIAISON NES FLU A/B, RSV, & COVID-19
LIAISON PLEX Respiratory Flex Assay
Locations
4
Australia
Key Health - Bondi
Bondi Junction, New South Wales, Australia
Key Health - CBD South
Sydney, New South Wales, Australia
Key Health - Pagewood
Sydney, New South Wales, Australia
Maxwell Medical Group
Melbourne, Victoria, Australia
Start Date
May 6, 2024
Primary Completion Date
August 31, 2024
Completion Date
October 31, 2024
Last Updated
April 30, 2024
NCT07128615
NCT06305793
NCT04896853
NCT06622590
NCT05202379
NCT06567860
Lead Sponsor
DiaSorin Molecular LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions